A symposium named after Edwin G. Krebs, the only Nobel laureate to date from UC Davis, will feature a keynote address from UC Berkeley Nobel Laureate Jennifer Doudna.
The Krebs Symposium, hosted by the Department of Biochemistry and Molecular Medicine, is being held May 15 from noon to 5 p.m. at the UC Davis Conference Center in Davis.
Doudna, a biochemist, is a Howard Hughes Medical Institute Investigator at UC Berkeley and founder of the Innovative Genomics Institute. She is also the Li Ka Shing Chancellor's Professor of Biomedical Science.
Doudna won the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier, for the co-development of CRISPR-Cas9. The genome editing breakthrough has revolutionized biomedicine, enabling scientists to change or remove genes quickly and with great precision.
The namesake of the symposium, Edwin G. Krebs, was the founding chair of the Department of Biochemistry and Molecular Medicine. Krebs shared the Nobel Prize in Physiology or Medicine in 1992 with Edmond H. Fischer for "their discoveries concerning reversible protein phosphorylation as a biological regulatory mechanism."
Attendance at the Krebs Symposium is limited to 250 people. Lunch will be provided at the beginning of the event. Faculty, postdoctoral scholars, staff and students are invited to sign up with their UC Davis email address here. The deadline for registration is Monday, May 1.
Preliminary agenda
12:00 p.m. — Lunch
1:00 p.m. — Opening remarks from UC Davis Chancellor Gary May and Vice Dean for Research Kim Barrett
1:15 p.m. — Presentations from the Department of Biochemistry and Molecular Medicine
- Megan Dennis, associate professor
- Hongwu Chen, professor
- Henriette O'Geen, project scientist
2:30 p.m. — Keynote address from Jennifer Doudna, professor, UC Berkeley
4:00 p.m. — Poster session for students and post-doctoral scholars
